ERBB2 and neoplasm: In this study, basal-like tumours were mostly concentrated within the IHC 0 (43.7%) and TNBC (84.7%) groups compared to IHC 2+ (9.8%), IHC 1+ (15.2%), HER2-low (13.4%) and HR-positive tumours (3.9%).